Draper group scientists have been working hard on the new Oxford - AstraZeneca COVID vaccine. In this latest Nature Medicine article Jordan Barrett explores the antibody response to single and booster doses of the ChAdOx1 nCoV-19 vaccine.
See the full report here:
Barrett, Jordan R., et al. "Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses." Nature medicine (2020): 1-10.
